NCT05357339View on ClinicalTrials.gov

Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

July 10, 2023

Study Completion Date

December 1, 2023

Conditions
Sepsis, SevereSepsisSeptic Shock
Interventions
OTHER

20% Albumin

100ml boluses 20% Albumin

OTHER

Crystalloid

100ml bolus of crystalloid

Trial Locations (1)

D03 WK19

St James's Hospital, Dublin

All Listed Sponsors
collaborator

Grifols Biologicals, LLC

INDUSTRY

lead

Rachael Cusack

OTHER

NCT05357339 - Microcirculation Properties of Albumin for Fluid Resuscitation in Septic Shock | Biotech Hunter | Biotech Hunter